Found: 24
Select item for more details and to access through your institution.
Developmental pharmacokinetics of indomethacin in preterm neonates: Severely decreased drug clearance in the first week of life.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2023, v. 12, n. 1, p. 110, doi. 10.1002/psp4.12881
- By:
- Publication type:
- Article
Mechanistic Population Pharmacokinetics of Morphine in Neonates With Abstinence Syndrome After Oral Administration of Diluted Tincture of Opium.
- Published in:
- Journal of Clinical Pharmacology, 2016, v. 56, n. 8, p. 1009, doi. 10.1002/jcph.696
- By:
- Publication type:
- Article
Corticosteroid response predicts bronchopulmonary dysplasia status at 36 weeks in preterm infants treated with dexamethasone: A pilot study.
- Published in:
- Pediatric Pulmonology, 2022, v. 57, n. 7, p. 1760, doi. 10.1002/ppul.25928
- By:
- Publication type:
- Article
Association of time of first corticosteroid treatment with bronchopulmonary dysplasia in preterm infants.
- Published in:
- Pediatric Pulmonology, 2021, v. 56, n. 10, p. 3283, doi. 10.1002/ppul.25610
- By:
- Publication type:
- Article
Timing of postnatal corticosteroid treatment for bronchopulmonary dysplasia and its effect on outcomes.
- Published in:
- Pediatric Pulmonology, 2019, v. 54, n. 2, p. 165, doi. 10.1002/ppul.24202
- By:
- Publication type:
- Article
Improving Racial and Ethnic Equity in Clinical Trials Enrolling Pregnant and Lactating Individuals.
- Published in:
- Journal of Clinical Pharmacology, 2023, v. 63, p. S21, doi. 10.1002/jcph.2263
- By:
- Publication type:
- Article
Pharmacometabolomics of Respiratory Phenotypic Response to Dexamethasone in Preterm Infants at Risk for Bronchopulmonary Dysplasia.
- Published in:
- CTS: Clinical & Translational Science, 2019, v. 12, n. 6, p. 591, doi. 10.1111/cts.12659
- By:
- Publication type:
- Article
Developing a community-led rare disease ELSI research agenda.
- Published in:
- Orphanet Journal of Rare Diseases, 2024, v. 19, n. 1, p. 1, doi. 10.1186/s13023-023-02986-x
- By:
- Publication type:
- Article
Pharmacokinetic and pharmacodynamic principles: unique considerations for optimal design of neonatal clinical trials.
- Published in:
- Frontiers in Pediatrics, 2024, p. 1, doi. 10.3389/fped.2023.1345969
- By:
- Publication type:
- Article
The neonatal adverse event severity scale: current status, a stakeholders' assessment, and future perspectives.
- Published in:
- Frontiers in Pediatrics, 2024, p. 01, doi. 10.3389/fped.2023.1340607
- By:
- Publication type:
- Article
Health Equity Column: Framing the Importance of Health Equity and Antiracism in the NICU.
- Published in:
- Neonatology Today, 2021, v. 16, n. 10, p. 43, doi. 10.51362/neonatology.today/20211016104347
- By:
- Publication type:
- Article
Is There a Real Association of Racial Disparities With In-Hospital Outcomes in Severe Bronchopulmonary Dysplasia?—Reply.
- Published in:
- JAMA Pediatrics, 2023, v. 177, n. 1, p. 101, doi. 10.1001/jamapediatrics.2022.4455
- By:
- Publication type:
- Article
Association of Racial Disparities With In-Hospital Outcomes in Severe Bronchopulmonary Dysplasia.
- Published in:
- JAMA Pediatrics, 2022, v. 176, n. 9, p. 852, doi. 10.1001/jamapediatrics.2022.2663
- By:
- Publication type:
- Article
Patent Ductus Arteriosus: A Contemporary Perspective for the Pediatric and Adult Cardiac Care Provider.
- Published in:
- 2022
- By:
- Publication type:
- journal article
A call for increased inclusivity and global representation in pharmacogenetic testing.
- Published in:
- NPJ Genomic Medicine, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41525-024-00403-1
- By:
- Publication type:
- Article
Could Postnatal Age–Related Uridine Diphosphate Glucuronic Acid Be a Rate‐Limiting Factor in the Metabolism of Morphine During the First Week of Life?
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2019, v. 8, n. 7, p. 469, doi. 10.1002/psp4.12407
- By:
- Publication type:
- Article
Prospective assessment of inter-rater reliability of a neonatal adverse event severity scale.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1237982
- By:
- Publication type:
- Article
Commentary: The Injustice of Paediatric Drug Labelling in Canada -- A Call to Action.
- Published in:
- Healthcare Policy, 2023, v. 19, n. 1, p. 65, doi. 10.12927/hcpol.2023.27156
- By:
- Publication type:
- Article
Ursodeoxycholic acid versus phenobarbital for cholestasis in the Neonatal Intensive Care Unit.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Advancing Precision Medicine in Paediatrics: Past, present and future.
- Published in:
- Cambridge Prisms: Precision Medicine, 2023, v. 1, p. 1, doi. 10.1017/pcm.2022.14
- By:
- Publication type:
- Article
Is Anti–Vascular Growth Factor Therapy for Retinopathy of Prematurity Associated With Pulmonary Hypertension?—Reply.
- Published in:
- JAMA Ophthalmology, 2023, v. 141, n. 4, p. 408, doi. 10.1001/jamaophthalmol.2023.0009
- By:
- Publication type:
- Article
Pulmonary Hypertension in Preterm Infants Treated With Laser vs Anti-Vascular Endothelial Growth Factor Therapy for Retinopathy of Prematurity.
- Published in:
- 2022
- By:
- Publication type:
- journal article
The cellular and immunological dynamics of early and transitional human milk.
- Published in:
- Communications Biology, 2023, v. 6, n. 1, p. 1, doi. 10.1038/s42003-023-04910-2
- By:
- Publication type:
- Article
Physiologically Based Pharmacokinetics Modeling in the Neonatal Population—Current Advances, Challenges, and Opportunities.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 11, p. 2579, doi. 10.3390/pharmaceutics15112579
- By:
- Publication type:
- Article